Magnetic resonance imaging versus radionuclide scintigraphy for screening in bone metastases [2]

Clinical Radiology

Volumn 55, Issue 8, 2000, Pages 653-

  Evans, A J ^a   Robertson, J F R ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE; RADIOISOTOPE;

BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FEMALE; HORMONAL THERAPY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; ISOTOPE LABELING; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; BONE TUMOR; METASTASIS; METHODOLOGY; NOTE; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SPINE DISEASE;

BONE NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPINAL DISEASES;

EID: 0034522989     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1053/crad.2000.0417     Document Type: Article

References (6)

1. Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases
2. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomised trial
3. Impact of follow-up testing on survival and health related quality of life after treatment of primary breast cancer: A randomised trial
4. Bone scanning; lack of value in the follow-up of patients with breast cancer
5. The management of metastatic bone disease in the United Kingdom
6. Confirmation of a prognostic index in primary breast cancer